Accelerated Corneal Cross-linking With Different Riboflavin Solutions
Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
Following the Bunsen-Roscoe law, accelerated cross-linking protocols with higher irradiation
intensities and shorter irradiation times have been introduced. In addition, new riboflavin
solutions with HPMC (hydroxylpropyl methylcellulose) instead of dextran found its way into
CXL-treatment. The aim of this trial is to evaluate clinical outcomes in an accelerated
corneal collagen cross-linking protocol with different riboflavin solutions.